Recruiting studies: Appendiceal Mucinous Neoplasm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
Phase 2 · 2 location(s) · Prakash Pandalai · NCT04779554 Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms
Phase 2 · 1 location(s) · University of California, Irvine · NCT07693452 A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
Phase 1/Phase 2 · 9 location(s) · Apollo Therapeutics Ltd · NCT06399757 A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06207305 Molecular Profiling for Risk Stratification in Appendiceal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07587268 Genetics of Appendix Cancer Study
Phase N/A · 1 location(s) · Andreana Holowatyj, PhD, MSCI · NCT05734430 A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendice
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT05947838

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.